Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Mieres

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Recent Patents on Cardiovascular Drug Discovery|March 23, 2012
Stent selection in patients with myocardial infarction: drug eluting, biodegradable polymers or bare metal stents?Juan Mieres, Alfredo E Rodríguez
Future Cardiology|July 10, 2020
Increased incidence of serious late adverse events with drug-eluting stents when compared with coronary artery bypass surgery: a cause of concernJuan Mieres, Alfredo E Rodríguez, Carlos Fernández-Pereira, et al.
Current Cardiology Reports|February 22, 2017
Can We Improve the Outcomes of Multivessel Disease Using Modified SYNTAX and Residual SYNTAX Scores?Alfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Case Reports in Cardiology|September 9, 2015
Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical RiskJuan Mieres, Marcelo Menéndez, Carlos Fernández-Pereira, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 10, 2015
Modifying angiographic syntax score according to PCI strategy: lessons learnt from ERACI IV StudyAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 10, 2018
Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk scoreAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
The Journal of Invasive Cardiology|August 5, 2009
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registryGilberto Perez, Alfredo M Rodriguez-Granillo, Juan Mieres, et al.
Case Reports in Cardiology|May 19, 2016
Ventricular Septal Perforation after Biventricular Takotsubo Cardiomyopathy Successfully Repaired with an Amplatzer Device: First Report in the LiteratureAlfredo E Rodríguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2012
One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)Juan Mieres, Carlos Fernandez-Pereira, Gustavo Risau, et al.
Panminerva Medica|November 7, 2024
Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysisAlfredo M Rodriguez-Granillo, Walter Masson, Martin Lobo, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Recent Patents on Cardiovascular Drug Discovery|March 23, 2012
Stent selection in patients with myocardial infarction: drug eluting, biodegradable polymers or bare metal stents?Juan Mieres, Alfredo E Rodríguez
Future Cardiology|July 10, 2020
Increased incidence of serious late adverse events with drug-eluting stents when compared with coronary artery bypass surgery: a cause of concernJuan Mieres, Alfredo E Rodríguez, Carlos Fernández-Pereira, et al.
Current Cardiology Reports|February 22, 2017
Can We Improve the Outcomes of Multivessel Disease Using Modified SYNTAX and Residual SYNTAX Scores?Alfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Case Reports in Cardiology|September 9, 2015
Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical RiskJuan Mieres, Marcelo Menéndez, Carlos Fernández-Pereira, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 10, 2015
Modifying angiographic syntax score according to PCI strategy: lessons learnt from ERACI IV StudyAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 10, 2018
Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: The ERACI risk scoreAlfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
The Journal of Invasive Cardiology|August 5, 2009
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registryGilberto Perez, Alfredo M Rodriguez-Granillo, Juan Mieres, et al.
Case Reports in Cardiology|May 19, 2016
Ventricular Septal Perforation after Biventricular Takotsubo Cardiomyopathy Successfully Repaired with an Amplatzer Device: First Report in the LiteratureAlfredo E Rodríguez, Carlos Fernandez-Pereira, Juan Mieres, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2012
One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)Juan Mieres, Carlos Fernandez-Pereira, Gustavo Risau, et al.
Panminerva Medica|November 7, 2024
Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysisAlfredo M Rodriguez-Granillo, Walter Masson, Martin Lobo, et al.
Pageof 2